News

COLLECTIVE WISDOM: KIDNEY CANCER UPDATES FROM ASCO 2016

See our latest blog for highlights on the American Society of Clinical Oncology (ASCO) meeting held in Chicago from June 3 to June 7. Read blog on this link

Posted June 22, 2016

NATIONAL PATIENT & CAREGIVER SURVEY

We want to know the needs and barriers around access to treatment, information and support for kidney cancer patients and their caregivers across Canada. We need your help to identify areas of improvement in your province so that we can develop new advocacy, education and support strategies for people touched by kidney cancer. Details and survey on this link

Posted June 15, 2016

UPDATE ON ACCESS TO IMMUNO-ONCOLGY TREATMENTS IN CANADA

Many patients and families are interested in the progress of immuno-oncology treatments as they apply to kidney cancer. Many of these treatments are in ongoing clinical trials across Canada. Kidney Cancer Canada is tracking all clinical trials and compassionate access programs. More information on this link.

Posted December 10, 2015

 

 

 

Events

Patient Education Meeting in Halifax 
Thursday, April 21, 2016
VIDEO ARCHIVE NOW ONLINE!

 

Patient & Caregiver Forum
Saturday, March 5, 2016
VIDEO ARCHIVE NOW ONLINE!

 

Keep visiting our website for the next scheduled patient meetings.

Latest Tweets

Kidney Cancer Canada

Kidney Cancer Canada @KidneyCancer_Ca

16h

New data presented at #ASCO16 showing that cabozantinib had an OS benefit over everolimus in 2nd line treatment bit.ly/28PqrTb

Kidney Cancer Canada

Kidney Cancer Canada @KidneyCancer_Ca

19h

La remise de la médaille #DSMCivile photos: Adj Ronald Duchesne, Rideau Hall ©BSGG 2016 @DebMaskensKCC #CancerduRein https://t.co/nzL5eeOtbM

Kidney Cancer Canada

Kidney Cancer Canada @KidneyCancer_Ca

19h

Receiving #MSDCivil - photos: WO Ronald Duchesne, Rideau Hall © OSGG, 2016 @DebMaskensKCC #KidneyCancer https://t.co/mNIIhke581

The Canadian Urological Association (CUA) endorses Kidney Cancer Canada and its mission; this does not necessarily equate to endorsement of this website's contents.
LinkedIn Google Plus Twitter Facebook Youtube Instagram Wordpress